Efficacy, Mechanisms and Safety of SGLT2 Inhibitors in Kidney Transplant Recipients
Clinical trial NCT04965935 · COMPLETED
Trial details
- NCT number
- NCT04965935
- Sponsor
- University Health Network, Toronto
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-15
- Primary completion
- 2024-08-30
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.